 GAITHERSBURG, Md., March 01, 2021 GLOBE NEWSWIRE -- OpGen, Inc. Nasdaq: OPGN, OpGen, a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, announced today that it has recently received regulatory approval of the Curetis Unyvero System as an in vitro diagnostics IVD instrument system in China from the Chinese authorities National Medical Products Administration, NMPA. The Medical Device Registration Certificate has been issued under the Registration number 20213220019. 